Eli Lilly CEO Banking On New Drug Pipeline

Even after the ImClone deal, we remain in a strong financial position, and we have the wherewithal to do additional deals, but we're going to approach that very, very thoughtfully.

Q. Are biotechs still attractive?

A. Yes, I think there are lots of opportunities, and it's not all mergers and acquisitions. At any one time, we have a lot of discussions going on about licensing opportunities or partnerships of some kind.

Q. You're juggling a lot right now, not unlike your parents. They raised nine children in a three-bedroom house. What did you learn from them that helped shape you in your current role?

A. I remember when the car industry really turned down in the 70s. I don't think my dad told me everything, but I mean the domestic auto industry during the oil shock in the 70s was just absolutely on its knees and then struggled again in the early 80s.

You know, he never gave up. They kept their dealership open, and he found a way to provide for us all. You succeed by continuing to show up. You work hard, you do the right thing.